Published in Invest Ophthalmol Vis Sci on August 01, 2011
Progress in corneal wound healing. Prog Retin Eye Res (2015) 1.02
A study of the activity and effectiveness of recombinant fibroblast growth factor (Q40P/S47I/H93G rFGF-1) in anti-aging treatment. Postepy Dermatol Alergol (2016) 0.75
Human Serum Eye Drops in Eye Alterations: An Insight and a Critical Analysis. J Ophthalmol (2015) 0.75
The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy (2010) 2.07
Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res (2005) 1.89
Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy (2013) 1.80
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials (2007) 1.77
New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol (2006) 1.72
Platelets and wound healing. Front Biosci (2008) 1.56
Shedding light in the controversial terminology for platelet rich products. J Biomed Mater Res A (2009) 1.54
A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy (2012) 1.51
Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. J Control Release (2009) 1.48
Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Med (2009) 1.46
Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A (2006) 1.43
Rigorous methodology is the school of coherent conclusions in science. Eur J Oral Implantol (2013) 1.41
The Effect of Plasma Rich in Growth Factors on Pattern Hair Loss: A Pilot Study. Dermatol Surg (2017) 1.37
The role of pH dynamics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin--one single nature. Biochim Biophys Acta (2005) 1.36
Microcapsules and microcarriers for in situ cell delivery. Adv Drug Deliv Rev (2010) 1.33
Corneal biomechanical changes after collagen cross-linking from porcine eye inflation experiments. Invest Ophthalmol Vis Sci (2010) 1.32
Cell microencapsulation technology: towards clinical application. J Control Release (2008) 1.26
Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater (2008) 1.20
Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy (2010) 1.15
Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials (2009) 1.11
A biological approach to orthopaedic surgery: are they lost in translation? Arthroscopy (2013) 1.08
Delivering growth factors for therapeutics. Trends Pharmacol Sci (2007) 1.07
Platelet-rich plasma and myofibroblasts: is the composition the key to success? Adv Skin Wound Care (2015) 1.07
Causality in biology has to answer 2 main questions--which and how: letter to the editor. Am J Sports Med (2013) 1.06
Tendon healing and platelet-rich plasma therapies. Expert Opin Biol Ther (2010) 1.06
Validation of the estimation of corneal aberrations from videokeratography in keratoconus. J Refract Surg (2002) 1.04
Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials (2006) 1.04
Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res (2009) 1.03
Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangers. Curr Alzheimer Res (2007) 0.97
Influence of implant length, diameter, and geometry on stress distribution: a finite element analysis. Int J Periodontics Restorative Dent (2010) 0.96
Biomaterials in cell microencapsulation. Adv Exp Med Biol (2010) 0.95
Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release (2011) 0.95
Reciprocal actions of platelet-secreted TGF-beta1 on the production of VEGF and HGF by human tendon cells. Plast Reconstr Surg (2007) 0.95
Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev (2010) 0.94
Clinical outcome of immediately loaded dental implants bioactivated with plasma rich in growth factors: a 5-year retrospective study. J Periodontol (2008) 0.93
Short implants in maxillae and mandibles: a retrospective study with 1 to 8 years of follow-up. J Periodontol (2010) 0.93
Nerve growth factor promotes corneal epithelial migration by enhancing expression of matrix metalloprotease-9. Invest Ophthalmol Vis Sci (2013) 0.93
Bilateral sinus elevation evaluating plasma rich in growth factors technology: a report of five cases. Clin Implant Dent Relat Res (2010) 0.91
Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-β1-induced myodifferentiation. J Periodontol (2011) 0.89
The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer's disease. Biomaterials (2010) 0.89
Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D. Trends Biotechnol (2012) 0.89
A preliminary approach to the repair of myocardial infarction using adipose tissue-derived stem cells encapsulated in magnetic resonance-labelled alginate microspheres in a porcine model. Eur J Pharm Biopharm (2012) 0.89
Release kinetics of platelet-derived and plasma-derived growth factors from autologous plasma rich in growth factors. Ann Anat (2013) 0.88
Plasma rich in growth factors promotes bone tissue regeneration by stimulating proliferation, migration, and autocrine secretion in primary human osteoblasts. J Periodontol (2012) 0.87
A multicentre placebo-controlled randomised clinical trial of antibiotic prophylaxis for placement of single dental implants. Eur J Oral Implantol (2009) 0.86
Clinical evaluation of Tiny® 2.5- and 3.0-mm narrow-diameter implants as definitive implants in different clinical situations: a retrospective cohort study. Eur J Oral Implantol (2010) 0.85
Hydrogel-based scaffolds for enclosing encapsulated therapeutic cells. Biomacromolecules (2013) 0.85
The effects of PRGF on bone regeneration and on titanium implant osseointegration in goats: a histologic and histomorphometric study. J Biomed Mater Res A (2009) 0.84
The importance of understanding what is platelet-rich growth factor (PRGF) and what is not. J Shoulder Elbow Surg (2010) 0.84
Five-year clinical evaluation of short dental implants placed in posterior areas: a retrospective study. J Periodontol (2008) 0.84
The use of plasma rich in growth factors (PRGF-Endoret) in the treatment of a severe mal perforant ulcer in the foot of a person with diabetes. Diabetes Res Clin Pract (2011) 0.84
Endogenous regenerative technology using plasma- and platelet-derived growth factors. J Control Release (2011) 0.84
Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg (2014) 0.83
Controlled ridge expansion using a two-stage split-crest technique with ultrasonic bone surgery. Implant Dent (2012) 0.83
Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis. Gynecol Endocrinol (2013) 0.83
A biological therapy to osteoarthritis treatment using platelet-rich plasma. Expert Opin Biol Ther (2013) 0.82
In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules. Biomacromolecules (2007) 0.82
Time-dependent release of growth factors from implant surfaces treated with plasma rich in growth factors. J Biomed Mater Res A (2012) 0.82
Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int J Pharm (2007) 0.82
Inferior intrastromal corneal ring segments in paracentral keratoconus with no coincident topographic and coma axis. J Refract Surg (2013) 0.80
A new approach for atraumatic implant explantation and immediate implant installation. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.80
Implant survival and crestal bone loss around extra-short implants supporting a fixed denture: the effect of crown height space, crown-to-implant ratio, and offset placement of the prosthesis. Int J Oral Maxillofac Implants (2014) 0.80
Endogenous morphogens and fibrin bioscaffolds for stem cell therapeutics. Trends Biotechnol (2013) 0.80
Biocompatibility and in vivo evaluation of oligochitosans as cationic modifiers of alginate/Ca microcapsules. J Biomed Mater Res A (2009) 0.80
Therapeutic cell encapsulation: ten steps towards clinical translation. J Control Release (2013) 0.80
Clinical evaluation of split-crest technique with ultrasonic bone surgery for narrow ridge expansion: status of soft and hard tissues and implant success. Clin Implant Dent Relat Res (2011) 0.80
Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease. PLoS One (2013) 0.80
Clinical, radiographical, and histological outcomes of plasma rich in growth factors in extraction socket: a randomized controlled clinical trial. Clin Oral Investig (2014) 0.79
Improvement of the monitoring and biosafety of encapsulated cells using the SFGNESTGL triple reporter system. J Control Release (2010) 0.79
Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells. Cancer Immunol Immunother (2010) 0.79
Corneal light transmission and roughness after refractive surgery. Optom Vis Sci (2010) 0.79
Emerging technologies in the delivery of erythropoietin for therapeutics. Med Res Rev (2011) 0.79
Cryopreservation based on freezing protocols for the long-term storage of microencapsulated myoblasts. Biomaterials (2009) 0.79
Stem cells in alginate bioscaffolds. Ther Deliv (2012) 0.79
Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology. Ther Deliv (2013) 0.78
Intrastromal corneal ring segment implantation in paracentral keratoconus with coincident topographic and coma axis. J Cataract Refract Surg (2012) 0.78
A lateral approach for sinus elevation using PRGF technology. Clin Implant Dent Relat Res (2009) 0.78
The type of platelet-rich plasma may influence the safety of the approach. Knee Surg Sports Traumatol Arthrosc (2012) 0.78
Behaviour and ultrastructure of human bone marrow-derived mesenchymal stem cells immobilised in alginate-poly-l-lysine-alginate microcapsules. J Microencapsul (2014) 0.78
A perspective on bioactive cell microencapsulation. BioDrugs (2012) 0.78
Tales of biomaterials, molecules, and cells for repairing and treating brain dysfunction. Curr Stem Cell Res Ther (2011) 0.78
5-year clinical experience with BTI dental implants: risk factors for implant failure. J Clin Periodontol (2008) 0.78
An autologous platelet-rich plasma stimulates periodontal ligament regeneration. J Periodontol (2013) 0.77
Retrospective study of short and extra-short implants placed in posterior regions: influence of crown-to-implant ratio on marginal bone loss. Clin Implant Dent Relat Res (2013) 0.77
Design of a composite drug delivery system to prolong functionality of cell-based scaffolds. Int J Pharm (2010) 0.77
Long-term retrospective evaluation of short implants in the posterior areas: clinical results after 10-12 years. J Clin Periodontol (2014) 0.77
Platelet-rich plasma to improve the bio-functionality of biomaterials. BioDrugs (2013) 0.77
Encapsulated VEGF-secreting cells enhance proliferation of neuronal progenitors in the hippocampus of AβPP/Ps1 mice. J Alzheimers Dis (2012) 0.77
[Cell encapsulation for the treatment of central nervous system disorders]. Rev Neurol (2010) 0.77
Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage. Cornea (2015) 0.77
Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye. Ophthalmic Res (2016) 0.77
Therapeutic applications of encapsulated cells. Methods Mol Biol (2013) 0.76
Novel technique for the treatment of the severely atrophied posterior mandible. Int J Oral Maxillofac Implants (2013) 0.76
An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS). Neuropsychiatr Dis Treat (2008) 0.76
Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months. Cornea (2013) 0.76
Advances in cell encapsulation technology and its application in drug delivery. Expert Opin Drug Deliv (2015) 0.76